Neumora Therapeutics, Inc. (NMRA) - What Are Researchers Thinking About This Stock?
MarketBeat
Neumora Therapeutics, Inc. (NASDAQ:NMRA - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the nine analysts that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation, six hav
NASDAQ:NMRA